Results 151 to 160 of about 10,172,451 (188)
Some of the next articles are maybe not open access.
Uses of cell free fetal DNA in maternal circulation
Best Practice & Research Clinical Obstetrics & Gynaecology, 2012For over a decade, researchers have focused their attention on the development of non-invasive prenatal diagnosis tests based on cell-free fetal DNA circulating in maternal blood. With the possibility of earlier and safer testing, non-invasive prenatal diagnosis has the potential to bring many positive benefits to prenatal diagnosis.
Melissa, Hill +3 more
openaire +2 more sources
Cell-free Fetal DNA — A Trigger for Parturition
New England Journal of Medicine, 2014Despite the importance of timing in parturition, little is known about its triggers. Emerging evidence supports an influential role for the level of cell-free fetal DNA.
openaire +2 more sources
Cell-Free Fetal DNA in Maternal Blood
JAMA, 2004N THIS ISSUE OF THE JOURNAL, THE FINDINGS REPORTED in the study by Dhallan and colleagues 1 on enhancing recovery of cell-free DNA in maternal blood have major clinical implications. Developing a reliable, transportabletechnologyforcell-freeDNAanalysisimpacts2crucial areas—prenatal genetic diagnosis and cancer detection and surveillance.
Joe Leigh Simpson, Farideh Bischoff
openaire +1 more source
Cell-Free Fetal DNA Testing for Prenatal Diagnosis
2016Prenatal diagnosis and screening have undergone rapid development in recent years, with advances in molecular technology driving the change. Noninvasive prenatal testing (NIPT) for Down syndrome as a highly sensitive screening test is now available worldwide through the commercial sector with many countries moving toward implementation into their ...
S, Drury, M, Hill, L S, Chitty
openaire +2 more sources
Cell-free Fetal DNA in Maternal Plasma
NeoReviews, 2008Since the discovery of cell-free fetal DNA (cffDNA) in peripheral maternal blood a decade ago, advances have been made in the identification and clinical application of these segments. Most studies of cffDNA have focused on using the segments for sex determination and fetal Rh genotyping, employing differences in genomic DNA between mother and fetus ...
James F. Smith, Yair Blumenfeld
openaire +1 more source
Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound
Journal of Perinatology, 2015Noninvasive prenatal testing utilizing free fetal DNA is commonly used in pregnancy to screen for trisomy 13, 18, 21 and also fetal sex aneuploidy. We report on two cases of discrepancy between phenotypic and genotypic sex and potential medical implications.
J I, Iruretagoyena, M, Grady, D, Shah
openaire +2 more sources
Early detection of cell-free fetal DNA in maternal plasma
Early Human Development, 2007We aimed to establish the earliest gestational age at which fetal DNA in maternal plasma could be detected and whether this was reliable at 12-13 weeks' gestation.A prospective observational cohort study of 32 pregnancies either after IVF or before prenatal diagnosis by CVS. Maternal blood was taken and RT-PCR was carried out to detect the multi-copy Y
S, Illanes +4 more
openaire +2 more sources
Cell-Free Fetal DNA in the Early and Late First Trimester
Fetal Diagnosis and Therapy, 2019<b><i>Objective:</i></b> The aim of this work was to investigate the association between maternal and fetal characteristics and the fetal fraction at 8–14 weeks’ gestation, with emphasis on the change in the fetal fraction upon repeat sampling.
Miltoft, Caroline Borregaard +4 more
openaire +3 more sources
Cell-free DNA screening for fetal aneuploidy as a clinical service
Clinical Biochemistry, 2015Non-invasive prenatal testing (NIPT) through the analysis of cell free (cf)DNA is revolutionizing prenatal screening for fetal aneuploidy. Current methods used in clinical practice include shotgun massively parallel sequencing (s-MPS); targeted (t-MPS); and an approach that takes advantage of single nucleotide polymorphism (SNP) differences between ...
Howard, Cuckle +2 more
openaire +2 more sources
Screening of Fetal Aneuploidies Using Fetal Cell-Free DNA
Fetal aneuploidies have been attempted to be screened since the 1970s. For this purpose, maternal age, various serum biochemical tests on maternal serum, and fetal ultrasonography have been used and are being used. However, it is observed that all these tests are insufficient to detect aneuploidies.Nevin Sagsoz, Zerrin Orbak
openaire +1 more source

